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Abstract  
BACKGROUND: Stroke is a leading cause of disability and remains the second leading cause of death in the 
world. Some of the pathogenesis of stroke are interactions between genetic and acquired risk factors, the 
interaction is related with the atherosclerotic which is the main pathogenesis of ischaemic stroke. Previous studies 
demonstrated an association between methylene tetra hydro folate reductase (MTHFR) genotype and ischaemic 
stroke; the MTHFR C677T genotype is one of the independent risk factor. 
AIM: This study aims to know about the role of polymorphism gen MTHFR C677T in ischaemic stroke patients 
with and without hypertension. 
METHODS: This study is a cross-sectional study, the sample was taken consecutively, after approval by the 
Medical Faculty Science’s Ethics Committee at University Sumatera Utara. All sample matched with inclusion and 
exclusion criteria, demography data and blood sample were taken. Demography data were analysed using 
descriptive statistic.  
RESULTS: Of the 106 ischaemic stroke patients were divided into two groups, the first group is patients with 
hypertension (53 patients), and the second group is without hypertension (53 patients). We have done the PCR- 
RFLP to all the patients, we got 78 patients with 677CC of MTHFR genotype, 23 patients with 677CT genotype 
and 5 patients with 677TT genotype. We found polymorphism C677T is more frequent in ischaemic stroke 
patients with hypertension (16 patients; 69.5%), and all the patient with 677TT genotype are an ischaemic stroke 
with hypertension (5 patients; 100%). 
CONCLUSION: We concluded that polymorphism MTHFR C677T have an important role in hypertension and 
ischaemic stroke. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Stroke remains a health problem in the world 
and as the major cause of morbidity, mortality and 
disability in developing country [1], [2], also in Asia, 
Russia, East Europe [3] and as multifactorial disease 
and complex caused by vascular, environment and 
genetic [4], [5]. The incidence of stroke increased in 
lower and middle-income countries. WHO predict in 
the year 2050, 80% of cases of stroke happened in 
that countries [4].  
Aetiology and pathogenesis of ischaemic 
stroke are complex and involved some risk factor [6], 
many evidence showed the role of genetic in stroke 
[4], but identification of the gen that related to stroke is 
still controversy [7]. A cohort study showed that family 
history with stroke would increase the risk of stroke 
[8], [9], and case-control study in twins also related to 
the inherited risk [10].  
Over the past decades, the role of a different 
candidate gene in the pathogenesis of stroke has 
been examined in numerous association studies [11]. 
The epidemiologic study shows the existence of basic 
polygene in stroke incidence and many stroke 
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pathogenesis, they act as interactions between 
genetic, and others risk factors [5], [7], the interaction 
related to atherosclerosis which is major pathogenesis 
of stroke [12]. Many gene and polymorphism have 
been studied as the cause of hypertension and act as 
a major risk factor for stroke [13]. 
The methylenetetrahydrofolate reductase 
C677T mutation is one of the most common gene 
polymorphisms. Mapped to chromosomal region 
1p36.3, the MTHFR gene spans a 2.2-kb length with 
11 exons and 10 introns [14] and encodes an enzyme 
composed of 656 amino acids [15]. The product, 
known as MTHFR, is a critical enzyme in 
homocysteine metabolism. The C677C to T mutation 
in the catalysing region of the MTHFR gene may 
induce the displacement of alanine by valine [16]. This 
change may lead to the thermolability of the enzyme 
and the inhibition of MTHFR activity, thus decreasing 
the transformation from 5,10 
methylenetetrahydrofolate to 5 
methyltetrahydrofolates [11], which act as a co-
substrate for the conversion from homocysteine to 
methionine [14].  
A lot of case-control studies have shown the 
role of C to T mutation in 677 nucleotides in the 
MTHFR gene; they found a significant relationships 
between C677T with hypertension in Caucasian and 
Asian population [13]. The MTHFR C677T 
polymorphism has previously been found to associate 
with various vascular disease including stroke, 
hypertension and congestive heart failure [11].  
Prevalence MTHFR C677T relatively high in 
general population, while the prevalence of T allele is 
about 0.34 (0.29-0.39) in whites, 0.42 (0.34-0.50) in 
Japanese and 0.08 (0.06-0.12) in African [17]. Other 
research shows that T allele frequency is much varied 
in different ethnic and country, 22.6% in the Guangxi 
Yao population, 32.2% in Australia, and 63.1% in 
Shandong [18]. 
People with MTHFR 677TT gene only have 
30% of enzyme activity, while the MTHFR C677T has 
60% of enzyme activity compared with the wild type 
[6]. T allele from MTHFR gene polymorphism is an 
independent risk factor of idiopathic ischaemic stroke 
[19], and prognostic factor for cardiovascular disease 
[20]. 
Genetic studies have a role in optimized 
stroke prevention and therapy [9], also can be used to 
predict the risk of the disease, but the results of the 
studies did not mention about the type and numerous 
gene that act as a stroke risk factor [7]. Significant 
improvement in the last few years about the role of 
genetic in stroke, giving deep knowledge about the 
basic molecular disease that can be used for the 
management patients [21] and to get new therapy 
target [10]. Identification of stroke risk factor can be 
modified to get stroke prevention more effective and 
decrease the mortality [3]. 
This study aims to know about the role of 
polymorphism gen MTHFR C677T in ischaemic stroke 
patients with and without hypertension. 
 
 
Material and Methods  
 
This study is a cross-sectional study; the 
sample was taken consecutively. The study was 
conducted with the approval of the ethics committee 
of the institutions involved, and informed consent was 
obtained from all subjects or their relatives (for 
comatose patients). Inclusion criteria were the 
presence of ischaemic stroke at the present hospital 
admission, age > 18 years old; the neurological 
deficits were confirmed in all cases by computerised 
tomography (CT) scan. We analysed the MTHFR 
genotypes in subjects with ischaemic stroke. The 
polymorphism was classified into three groups, (1) 
allele CC, (2) allele CT, (3) allele TT.  
A polymerase chain reaction followed by the 
restriction fragment length polymorphism was used to 
genotype the C677T polymorphism of MTHFR. The 
conditions of amplification and digestion have been 
well documented previously in our laboratory. The 
digested PCR products after separation on a 3% 
agarose gel, stained with ethidium bromide, showed 
one band of 198bp corresponding to the wild-type 
homozygous (CC), three bands of 198, 175, and 23bp 
for the heterozygous (CT), two bands of 175 and 23bp 
for the mutated homozygous (TT).  
 
 
Results  
 
This study includes 106 ischaemic stroke 
patients were divided into two groups, with and 
without hypertension. A total of 55 men had an 
ischaemic stroke, while 51 women had an ischaemic 
stroke, 60 patients at the age below 60 y.o, 46 
patients at the age above 60 y.o, Bataknese 33 
patients, family history was found in 32 patients. 
Table: 1 Distribution of characteristic frequency ischaemic 
stroke with and without hypertension 
Variable Category 
Ischaemic Stroke 
 
Hypertension Non-hypertension Total 
N % N % N % 
Age < 60 y.o 30 28,3 30 28.3 60 56.6 
 
> 60 y.o 23 21.7 23 21.7 46 43.4 
Gender Female 25 23.6 26 24.5 51 48.1 
 
Male 28 26.4 27 25.4 55 51.9 
Ethnicity  
 
 
 
 
 
Family 
history 
 Bataknese 
 Javanese 
 Acehnese 
 Minangnese 
 Melayumese 
 Niasnese 
 
33 
11 
4 
2 
2 
1 
 
32 
31.1 
10.4 
3.77 
1.88 
1.88 
0.94 
 
30.1 
29 
10 
3 
2 
9 
- 
 
17 
27.3 
9.43 
2.83 
1.88 
8.49 
- 
 
16.0 
62 
21 
7 
3 
11 
1 
 
49 
58.4 
19.8 
6.60 
2.83 
10.3 
0.94 
 
46.2 
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 The differences in the characteristics of 
patients with and without hypertension are shown in 
Table 1. 
Table: 2 Distribution of frequency polymorphism ischaemic 
stroke with and without hypertension 
Variable Category 
Ischaemic Stroke 
 
 
p-value* Hypertension Non-Hypertension Total 
n % n % n % 
 
Polymorphism CC 32 60.3 43 81.1 76 71.7 
0.035
 
 
CT 16 30.2 10 18.9 26 24.5 
 
TT 5 9.5 0 0 5 3.8 
*Fisher Exact Test 
 
This study found that among 106 patients 
ischaemic stroke with hypertension and without 
hypertension, the wild-type homozygous (CC) was 
found in 76 patients; 71.7% (32 patients with 
hypertension, 43 patients without hypertension). The 
heterozygous (CT) was found in 26 patients; 24.5% 
(16 patients with hypertension, 10 patients without 
hypertension). The mutated homozygous (TT) was 
found only in ischaemic stroke patients with 
hypertension (5 patients). 
Fisher exact test was done for this variable 
category; the result showed a significant correlation (p 
= 0.035) (Table 2). 
 
  
Discussion 
 
Stroke is a common complex trait and does 
not follow Mendelian pattern of inheritance: Gene–
gene or gene-environment interactions may be 
responsible for the complex trait. How the interactions 
contribute to stroke is still under research [12].  
Now we know single polymorphism may have 
a weak effect on the risk of stroke when analysed 
individually, but their influence may be more 
pronounced in the presence of a permissive 
background. Many cases of stroke are due to a 
complex interaction between lifestyle factors and 
genetic susceptibilities. Genetic predisposition for 
stroke may result from synergistic co effects [11]. 
Many studies have shown that T allele 
frequencies in different ethnicities and countries vary 
widely. The Guangxi Yao population rate was 22/6%, 
and in Australia, it was 32.2 %. The Yang et al., the 
study of 15,357 Han patients found that the mutation 
frequency in Hainan was the lowest with T allele of 
245 and in Shandong it was the highest (63.1%) [18].  
This study found that polymorphism C677T is 
more frequent in ischaemic stroke patients with 
hypertension (16 patients), and all the patient with 
677TT genotype are an ischaemic stroke with 
hypertension (5 patients), 
This gene is responsible for producing 
Methylenetetrahydrofolate reductase (MTHFR) 
enzyme that functional. The function of this enzyme is 
to transform 5, 10 methylenetetrahydrofolates to 5 
methyltetrahydrofolates [22]. The Val form of MTHFR 
encoded by 677 T allele is thermolabile and has 
reduced enzymatic activity [23]. The mutated 
homozygous (TT) is the risk of thrombotic disease in 
young age [24]. 
The result of this study showed a significant 
correlation between the polymorphism and ischaemic 
stroke with and without hypertension (p = 0.035). 
There is a strong association between 
polymorphism gen MTHFR with atherosclerosis; even 
the mechanism of it is indirect. Patients with MTHFR 
genotype 677TT, have a vascular occlusion, and 
infarct, had increased level of blood homocysteine. 
Those are the reason for the association between 
polymorphism and hypertension [12]. 
In conclusion, polymorphism MTHFR C677T 
has an important role in hypertension and ischaemic 
stroke, because both of the diseases is caused by 
atherosclerotic vascular disease. 
There are several limitations to our study. 
First, the study enrolled hospital-based stroke patients 
rather than patients from a community based general 
population. Secondly, this study did not collect data on 
other several major risk factors of ischaemic stroke. 
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